AGIOS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares Authorized from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Agios Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2012 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 125M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 125M 0 0% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 125M 0 0% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 125M 0 0% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 125M 0 0% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 125M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 125M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 125M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 125M 0 0% Dec 31, 2022 10-K 2024-02-15
Q3 2022 125M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 125M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 125M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 125M 0 0% Dec 31, 2021 10-K 2023-02-23
Q3 2021 125M 0 0% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 125M 0 0% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 125M 0 0% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 125M 0 0% Dec 31, 2020 10-K 2022-02-24
Q3 2020 125M 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 125M 0 0% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 125M 0 0% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 125M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 125M 0 0% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 125M 0 0% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 125M 0 0% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 125M 0 0% Dec 31, 2018 10-K 2020-02-19
Q3 2018 125M 0 0% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 125M 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 125M 0 0% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 125M 0 0% Dec 31, 2017 10-K 2019-02-14
Q3 2017 125M 0 0% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 125M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 125M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 125M 0 0% Dec 31, 2016 10-K 2018-02-14
Q3 2016 125M 0 0% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 125M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 125M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 125M 0 0% Dec 31, 2015 10-K 2017-02-16
Q3 2015 125M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 125M 0 0% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 125M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 125M 0 0% Dec 31, 2014 10-K 2016-02-26
Q3 2014 125M 0 0% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 125M +46.7M +59.6% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 125M Mar 31, 2014 10-Q 2014-05-09
Q4 2013 125M +46.7M +59.6% Dec 31, 2013 10-K 2015-02-24
Q3 2013 125M Sep 30, 2013 10-Q 2013-11-07
Q2 2013 78.3M Jun 30, 2013 10-Q 2013-09-05
Q4 2012 78.3M Dec 31, 2012 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.